Patents by Inventor Pier Paolo Pandolfi

Pier Paolo Pandolfi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146577
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146582
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146575
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146569
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146580
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146568
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20040146572
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: January 16, 2004
    Publication date: July 29, 2004
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Patent number: 6723351
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: April 20, 2004
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Jr., Pier Paolo Pandolfi, Janice L. Gabrilove
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20030211171
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: April 30, 2003
    Publication date: November 13, 2003
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove, Ralph Ellison, Steven Soignet
  • PROCESS FOR PRODUCING ARSENIC TRIOXIDE FORMULATIONS AND METHODS FOR TREATING CANCER USING ARSENIC TRIOXIDE OR MELARSOPROL
    Publication number: 20020013371
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: November 10, 1998
    Publication date: January 31, 2002
    Inventors: RAYMOND P. WARRELL, PIER PAOLO PANDOLFI, JANICE L. GABRILOVE
  • Transcription therapy for cancers
    Patent number: 6262116
    Abstract: The present invention provides method of treating a neoplastic condition in an individual, comprising the step of administering to said individual a pharmacologically effective dose of a retinoic acid and/or an inhibitor of histone deacetylase. Also provided is a pharmaceutical composition, comprising a retinoic acid, an inhibitor of histone deacetylase and a pharmaceutically acceptable carrier. Further provided is a method of inducing terminal differentiation of tumor cells in a tumor in an individual in need of such treatment, comprising the step of administering to said individual a pharmacologically effective dose of a retinoic acid and/or an inhibitor of histone deacetylase.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: July 17, 2001
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Pier Paolo Pandolfi, Raymond P. Warrell, Jr., Arthur Zelent